» Articles » PMID: 22503856

Extraction of Viral Nucleic Acids: Comparison of Five Automated Nucleic Acid Extraction Platforms

Overview
Journal J Clin Virol
Specialty Microbiology
Date 2012 Apr 17
PMID 22503856
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nucleic acid extraction has a major impact on the reliability of results in routine molecular diagnostics. Optimal isolation of nucleic acids and removal of inhibitors are essential.

Objectives: This study compares five different automated extraction platforms for the extraction of norovirus RNA from stool and cytomegalovirus (CMV) DNA from plasma samples.

Study Design: Norovirus positive stool samples and CMV positive plasma samples were aliquoted and analyzed using five different automated platforms (easyMAG, bioMerieux; m2000sp, Abbott; MagNA Pure LC 2.0, Roche; QiaSymphony, Qiagen; sample preparation module of the VERSANT kPCR Molecular System, Siemens). Similar sample input and output volumes, the identical real-time PCR cycler, and the identical assays for amplification and detection for norovirus RNA and CMV DNA, respectively, were chosen.

Results: Of 39 stool samples, 36 tested positive for norovirus RNA with all extraction platforms. The three discrepant samples showed inhibition after extraction with at least one platform. Only with the VERSANT platform all samples tested positive for both the target RNA and the internal controls. Of 42 plasma samples, 27 gave quantifiable results for CMV DNA with all extraction platforms. There was significant variance between viral concentrations when different extraction platforms were compared. The majority of the 15 discrepant samples showed low viral concentrations. The internal control of the CMV assay gave positive results for all samples tested below the limit of quantification.

Conclusions: The five automated extraction platforms yielded comparable results. However, the extraction performance was found to be impaired by inhibitory substances in stool samples.

Citing Articles

Optimization of extraction-free protocols for SARS-CoV-2 detection using a commercial rRT-PCR assay.

Kang M, Jeong E, Kim J, Yun S, Jang M, Jang J Sci Rep. 2023; 13(1):20364.

PMID: 37990045 PMC: 10663557. DOI: 10.1038/s41598-023-47645-0.


Nucleic Acid Based Testing (NABing): A Game Changer Technology for Public Health.

Khera H, Mishra R Mol Biotechnol. 2023; 66(9):2168-2200.

PMID: 37695473 DOI: 10.1007/s12033-023-00870-4.


Evaluation of DNA Extraction Methods for Reliable Quantification of , , and .

Bogozalec Kosir A, Luznik D, Tomic V, Milavec M Biosensors (Basel). 2023; 13(4).

PMID: 37185538 PMC: 10136035. DOI: 10.3390/bios13040463.


CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications.

Huang Z, Lyon C, Wang J, Lu S, Hu T Adv Sci (Weinh). 2023; 10(20):e2301697.

PMID: 37162202 PMC: 10369298. DOI: 10.1002/advs.202301697.


Forty Years of Molecular Diagnostics for Infectious Diseases.

Schmitz J, Stratton C, Persing D, Tang Y J Clin Microbiol. 2022; 60(10):e0244621.

PMID: 35852340 PMC: 9580468. DOI: 10.1128/jcm.02446-21.